UBIAD1
UBIAD1 (UbiA prenyltransferase domain containing 1, also known as TERE1 and SCCD) is a prenyltransferase that mediates the formation of menaquinone-4 and coenzyme Q10. It belongs to the UbiA prenyltransferase family and is linked to cholesterol and phospholipid metabolism. Browse Assay Genie's current range of UBIAD1 research reagents below, or read on for the biology behind the target.
UBIAD1 is a prenyltransferase that mediates the formation of menaquinone-4 (MK-4) and coenzyme Q10. MK-4 is a vitamin K2 isoform present at high concentrations in the brain, kidney and pancreas, and is required for endothelial cell development. UBIAD1 converts phylloquinone (vitamin K1) into MK-4, probably by cleaving the phylloquinone side chain to release menadione (K3) and then prenylating it with geranylgeranyl pyrophosphate (GGPP).
UBIAD1 also acts in cardiovascular development independently of MK-4 biosynthesis, as a coenzyme Q10 biosynthetic enzyme. Coenzyme Q10, also called ubiquinone, plays an important antioxidant role in the cardiovascular system. UBIAD1 mediates coenzyme Q10 biosynthesis in the Golgi membrane, which protects cardiovascular tissues from NOS3/eNOS-dependent oxidative stress. The protein is annotated to the endoplasmic reticulum membrane, Golgi apparatus membrane, mitochondrion membrane, cytoplasm and nucleus, and belongs to the UbiA prenyltransferase family. Two EC numbers, 2.5.1.- and 2.5.1.39, are assigned to it.
The UBIAD1 gene is thought to be involved in cholesterol and phospholipid metabolism. Mutations in the gene are associated with Schnyder crystalline corneal dystrophy, which explains the alias SCCD and the previous name Schnyder crystalline corneal dystrophy. The alias TERE1 is also used in the literature. Mouse and rat orthologs are both named Ubiad1.
UBIAD1 converts phylloquinone into menaquinone-4, a vitamin K2 isoform found at high levels in brain, kidney and pancreas.
UBIAD1 contributes to coenzyme Q10 (ubiquinone) biosynthesis in the Golgi membrane, making it a focus for studying this antioxidant pathway.
UBIAD1 supports cardiovascular development and helps protect cardiovascular tissues from NOS3/eNOS-dependent oxidative stress.
Mutations in the UBIAD1 gene are associated with Schnyder crystalline corneal dystrophy, linking the protein to cholesterol and phospholipid metabolism.
UBIAD1 is a prenyltransferase that forms menaquinone-4 (vitamin K2) from phylloquinone and geranylgeranyl pyrophosphate, and also biosynthesises coenzyme Q10 in the Golgi membrane. Through coenzyme Q10 it helps protect cardiovascular tissues from NOS3/eNOS-dependent oxidative stress.
The HGNC name is UbiA prenyltransferase domain containing 1. Aliases include TERE1 and SCCD, and the previous name is Schnyder crystalline corneal dystrophy, reflecting its disease association. UniProt lists the protein as UbiA prenyltransferase domain-containing protein 1, with EC numbers 2.5.1.- and 2.5.1.39.
Mutations in the UBIAD1 gene are associated with Schnyder crystalline corneal dystrophy. Orthologs exist in mouse and rat, both named Ubiad1. Check the datasheet of any product for its validated reactivity.
Other prenyltransferases, coenzyme Q and vitamin K pathway enzymes, and cardiovascular oxidative stress markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y5Z9; product specifications from Assay Genie datasheets.